BioTech Weekly - Aug 11-17, 2025 (Week 33)
Description
🚀 Biotech & Life Sciences – Latest Highlights
🔹 VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer
🔹 Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results
🔹 Allonnia and Eagle Mine Partner to Deploy D-Solve™ Technology to Unlock More Nickel
🔹 Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale
🔹 Medidata Accelerates Business Transformation with Lisa Moneymaker as Chief Strategy Officer
🔹 Ousted FDA vaccine chief Vinay Prasad is returning to the agency
🔹 Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of Lucid-MS
🔹 BinSentry Raises $50 Million to Modernize Animal Feed Supply Chains
🔹 Quantum BioPharma Announces Promising PET Tracer Results for MS Patients
🔹 PharmAla Delivers MDMA to Merhavim Mental Health Centre Clinical Trial
🔹 Oncomatryx Biopharma Awarded €12.5 Million EIC Accelerator Funding
🔹 Optogenetic platform enables precise discovery of anti-aging therapeutics
🌍 From neuropsychiatry breakthroughs to advanced toxicology models, oncology innovations, sustainable mining, and next-gen biotech platforms—the sector is moving fast.
✨ Which of these innovations do you think will have the biggest impact in the next 5 years?
#Biotech #LifeSciences #Pharma #AgTech #HealthcareInnovation #ClinicalTrials #DrugDevelopment #Sustainability #NeurodegenerativeDiseases #Oncology #AIinHealthcare #MedTech
United States
